Cargando…

Identification of SCN7A as the key gene associated with tumor mutation burden in gastric cancer

OBJECTIVE: Previous studies have shown that tumor mutation burden (TMB) in cancer is associated with prognosis. The purpose of this study is to identify TMB related genes in gastric cancer (GC) and to explore their prognostic value. METHODS: In our research, weighted gene coexpression network analys...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Wenjie, Zhou, Kezhi, Li, Mengting, Hu, Qian, Wei, Wanhui, Liu, Lan, Zhao, Qiu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8817579/
https://www.ncbi.nlm.nih.gov/pubmed/35123417
http://dx.doi.org/10.1186/s12876-022-02112-4
_version_ 1784645676959793152
author Li, Wenjie
Zhou, Kezhi
Li, Mengting
Hu, Qian
Wei, Wanhui
Liu, Lan
Zhao, Qiu
author_facet Li, Wenjie
Zhou, Kezhi
Li, Mengting
Hu, Qian
Wei, Wanhui
Liu, Lan
Zhao, Qiu
author_sort Li, Wenjie
collection PubMed
description OBJECTIVE: Previous studies have shown that tumor mutation burden (TMB) in cancer is associated with prognosis. The purpose of this study is to identify TMB related genes in gastric cancer (GC) and to explore their prognostic value. METHODS: In our research, weighted gene coexpression network analysis (WGCNA) algorithm was used to cluster the most relevant TMB modules in the Cancer Genome Atlas (TCGA) database. Limma package was used to screen the differentially expressed genes, and the intersection was identified as hub genes. We used gene expression profiling interactive analysis (GEPIA) and survival algorithm to analyze the clinical characteristics and prognosis of hub genes in tumor and normal tissue samples of TCGA and Gene Expression Omnibus cohort respectively. We also used CIBERSORT algorithm to calculate the proportion of 22 tumor immune cells in the high and low expression subgroups of hub genes. In addition, we used gene set enrichment analysis (GSEA) to predict the biological function of hub genes. P < 0.05 was considered statistically significant. RESULTS: In the TCGA cohort, TMB was significantly correlated with the clinical features of GC (P < 0.05). Through WGCNA and differential gene analysis, we identified SCN7A as the hub gene (P < 0.05, |log2fc|> 1, and mm > 0.8). We found that the expression of SCN7A in tumor tissues was lower than that in normal tissues, and its expression level was also related to overall survival rate and tumor stage. GSEA analysis showed that SCN7A low expression group was enriched with "DNA replication", "base extension repair" and "proteasome" gene sets in GC. In addition, we found that there were significant differences in the infiltration degree of 7 kinds of immune cells between the two groups. CONCLUSION: TMB can indicate the prognosis of gastric cancer. SCN7A is a hub gene associated with TMB, and its low expression is associated with better prognosis. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12876-022-02112-4.
format Online
Article
Text
id pubmed-8817579
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-88175792022-02-07 Identification of SCN7A as the key gene associated with tumor mutation burden in gastric cancer Li, Wenjie Zhou, Kezhi Li, Mengting Hu, Qian Wei, Wanhui Liu, Lan Zhao, Qiu BMC Gastroenterol Research OBJECTIVE: Previous studies have shown that tumor mutation burden (TMB) in cancer is associated with prognosis. The purpose of this study is to identify TMB related genes in gastric cancer (GC) and to explore their prognostic value. METHODS: In our research, weighted gene coexpression network analysis (WGCNA) algorithm was used to cluster the most relevant TMB modules in the Cancer Genome Atlas (TCGA) database. Limma package was used to screen the differentially expressed genes, and the intersection was identified as hub genes. We used gene expression profiling interactive analysis (GEPIA) and survival algorithm to analyze the clinical characteristics and prognosis of hub genes in tumor and normal tissue samples of TCGA and Gene Expression Omnibus cohort respectively. We also used CIBERSORT algorithm to calculate the proportion of 22 tumor immune cells in the high and low expression subgroups of hub genes. In addition, we used gene set enrichment analysis (GSEA) to predict the biological function of hub genes. P < 0.05 was considered statistically significant. RESULTS: In the TCGA cohort, TMB was significantly correlated with the clinical features of GC (P < 0.05). Through WGCNA and differential gene analysis, we identified SCN7A as the hub gene (P < 0.05, |log2fc|> 1, and mm > 0.8). We found that the expression of SCN7A in tumor tissues was lower than that in normal tissues, and its expression level was also related to overall survival rate and tumor stage. GSEA analysis showed that SCN7A low expression group was enriched with "DNA replication", "base extension repair" and "proteasome" gene sets in GC. In addition, we found that there were significant differences in the infiltration degree of 7 kinds of immune cells between the two groups. CONCLUSION: TMB can indicate the prognosis of gastric cancer. SCN7A is a hub gene associated with TMB, and its low expression is associated with better prognosis. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12876-022-02112-4. BioMed Central 2022-02-05 /pmc/articles/PMC8817579/ /pubmed/35123417 http://dx.doi.org/10.1186/s12876-022-02112-4 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Li, Wenjie
Zhou, Kezhi
Li, Mengting
Hu, Qian
Wei, Wanhui
Liu, Lan
Zhao, Qiu
Identification of SCN7A as the key gene associated with tumor mutation burden in gastric cancer
title Identification of SCN7A as the key gene associated with tumor mutation burden in gastric cancer
title_full Identification of SCN7A as the key gene associated with tumor mutation burden in gastric cancer
title_fullStr Identification of SCN7A as the key gene associated with tumor mutation burden in gastric cancer
title_full_unstemmed Identification of SCN7A as the key gene associated with tumor mutation burden in gastric cancer
title_short Identification of SCN7A as the key gene associated with tumor mutation burden in gastric cancer
title_sort identification of scn7a as the key gene associated with tumor mutation burden in gastric cancer
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8817579/
https://www.ncbi.nlm.nih.gov/pubmed/35123417
http://dx.doi.org/10.1186/s12876-022-02112-4
work_keys_str_mv AT liwenjie identificationofscn7aasthekeygeneassociatedwithtumormutationburdeningastriccancer
AT zhoukezhi identificationofscn7aasthekeygeneassociatedwithtumormutationburdeningastriccancer
AT limengting identificationofscn7aasthekeygeneassociatedwithtumormutationburdeningastriccancer
AT huqian identificationofscn7aasthekeygeneassociatedwithtumormutationburdeningastriccancer
AT weiwanhui identificationofscn7aasthekeygeneassociatedwithtumormutationburdeningastriccancer
AT liulan identificationofscn7aasthekeygeneassociatedwithtumormutationburdeningastriccancer
AT zhaoqiu identificationofscn7aasthekeygeneassociatedwithtumormutationburdeningastriccancer